Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

959 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conditional survival in multiple myeloma and impact of prognostic factors over time.
Abdallah NH, Smith AN, Geyer S, Binder M, Greipp PT, Kapoor P, Dispenzieri A, Gertz MA, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Hwa YL, Lin Y, Kourelis T, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Abdallah NH, et al. Among authors: binder m. Blood Cancer J. 2023 May 15;13(1):78. doi: 10.1038/s41408-023-00852-4. Blood Cancer J. 2023. PMID: 37188699 Free PMC article.
Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma.
Binder M, Rajkumar SV, Ketterling RP, Greipp PT, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Hwa YL, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Gonsalves WI, Kyle RA, Kumar SK. Binder M, et al. Blood Cancer J. 2017 Sep 1;7(9):e600. doi: 10.1038/bcj.2017.83. Blood Cancer J. 2017. PMID: 28862698 Free PMC article.
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
Mellors PW, Binder M, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Kapoor P, Gonsalves WI, Hwa YL, Fonder A, Hobbs M, Kourelis T, Warsame R, Zeldenrust SR, Lust JA, Leung N, Go RS, Kyle RA, Vincent Rajkumar S, Kumar SK. Mellors PW, et al. Among authors: binder m. Am J Hematol. 2018 Jul;93(7):889-894. doi: 10.1002/ajh.25113. Am J Hematol. 2018. PMID: 29659048 Free article.
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.
Lakshman A, Rajkumar SV, Buadi FK, Binder M, Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, Go RS, Lin Y, Kourelis TV, Warsame R, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK. Lakshman A, et al. Among authors: binder m. Blood Cancer J. 2018 Jun 12;8(6):59. doi: 10.1038/s41408-018-0077-4. Blood Cancer J. 2018. PMID: 29895887 Free PMC article.
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
Binder M, Rajkumar SV, Lacy MQ, Gertz MA, Buadi FK, Dispenzieri A, Hwa YL, Fonder A, Hobbs M, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Gonsalves WI, Kourelis T, Warsame R, Kyle RA, Kumar SK. Binder M, et al. Am J Hematol. 2019 Mar;94(3):306-311. doi: 10.1002/ajh.25365. Epub 2018 Dec 13. Am J Hematol. 2019. PMID: 30516847 Free article.
Substratification of patients with newly diagnosed standard-risk multiple myeloma.
Binder M, Rajkumar SV, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Hwa YL, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Gonsalves WI, Kyle RA, Kumar SK. Binder M, et al. Br J Haematol. 2019 Apr;185(2):254-260. doi: 10.1111/bjh.15800. Epub 2019 Feb 15. Br J Haematol. 2019. PMID: 30768679 Free article.
Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma.
Mellors PW, Binder M, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Kapoor P, Gonsalves WI, Hwa YL, Fonder A, Hobbs M, Kourelis T, Warsame R, Zeldenrust SR, Lust JA, Leung N, Go RS, Kyle RA, Rajkumar SV, Kumar SK. Mellors PW, et al. Among authors: binder m. Leuk Lymphoma. 2019 Dec;60(12):2960-2967. doi: 10.1080/10428194.2019.1613536. Epub 2019 May 16. Leuk Lymphoma. 2019. PMID: 31096812
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis.
Sidana S, Milani P, Binder M, Basset M, Tandon N, Foli A, Dispenzieri A, Gertz MA, Hayman SR, Buadi FK, Lacy MQ, Kapoor P, Leung N, Rajkumar SV, Merlini G, Palladini G, Kumar SK. Sidana S, et al. Among authors: binder m. Blood Cancer J. 2020 Apr 14;10(4):41. doi: 10.1038/s41408-020-0306-5. Blood Cancer J. 2020. PMID: 32286270 Free PMC article.
959 results